Search
Nautilus Biotechnology Inc
NAUTAdd to Watchlist
0.955USD
-0.011-1.14%
Close 09-21 16:00（ET）
121.50MMarket Cap
LossP/E TTM
Nautilus Biotechnology Inc (NAUT) Stock Price Target & Forecast
Analyst Rating
Based on 3 analysts giving stock ratings to Nautilus Biotechnology Inc in the past month.
Strong Buy
2 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
4.000USD+314.08%
NAUT Analyst Recommendation Trends
In the current month, NAUT has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NAUT average Analyst price target in the last month is 4.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
2
2
2
2
2
2
2
Financial Forecasting
Based on analysts' estimates, NAUT EPS is projected to reach -0.140 in FY2026Q3, following reported EPS of -0.114 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.14
-0.14
-0.14
-0.14
-0.13
Actual
-0.11
-0.12
-0.11
--
--
Surprise
+22.11%
+19.96%
+15.70%
--
--
FAQs
What is Nautilus Biotechnology Inc's price target?
Analysts forecast that Nautilus Biotechnology Inc's price target is USD 2.50, with the highest forecast at USD 2.50 and the lowest forecast at USD 2.50.
How have Nautilus Biotechnology IncNAUT's recent earnings per share performed?
The market expectation was USD -0.11, while Nautilus Biotechnology IncNAUT's earnings per share (EPS) for the previous quarter was USD -0.12. EPS for the next quarter is expected at USD -0.14.
What is the analyst rating for Nautilus Biotechnology Inc?
Based on the ratings of Nautilus Biotechnology Inc's stock from 3 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.